Anti-ERBB3/HER3 Antibody (Barecetamab)
Catalog No.
F1415
Anti-ERBB3/HER3 Antibody (Barecetamab)
Featured Products
Barecetamab (ISU-104) is a humanized anti-ErbB3 monoclonal antibody. Barecetamab is indicated for the treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.9 kDa
Dry ice
2275727-74-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Barecetamab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P21860
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human HER3 His at 2 ug/mL can bind Anti-ERBB3/HER3 Antibody (Barecetamab)
ERBB3 / HER3
Please avoid freeze-thaw cycles.